SEC Comment Letter 0000000000-23-012525 to ATHERSYS, INC / NEW (ATHXQ) (CIK 0001368148)
ATHERSYS, INC / NEW (ATHXQ) (CIK 0001368148)
Date: Nov. 15, 2023 · CIK: 0001368148 · Accession: 0000000000-23-012525
AI Filing Summary & Sentiment
File numbers found in text: 333-275458
Letter
United States securities and exchange commission logo November 15, 2023 Daniel Camardo Chief Executive Officer Athersys, Inc. 3201 Carnegie Avenue Cleveland, OH 44115-2634 Re:Athersys, Inc. Registration Statement on Form S-1 Filed November 9, 2023 File No. 333-275458 Dear Daniel Camardo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Faith Charles
Show Raw Text
United States securities and exchange commission logo
November 15, 2023
Daniel Camardo
Chief Executive Officer
Athersys, Inc.
3201 Carnegie Avenue
Cleveland, OH 44115-2634
Re:Athersys, Inc.
Registration Statement on Form S-1
Filed November 9, 2023
File No. 333-275458
Dear Daniel Camardo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Faith Charles